Literature DB >> 10512521

Are preoperative obesity and cachexia risk factors for post heart transplant morbidity and mortality: a multi-institutional study of preoperative weight-height indices. Cardiac Transplant Research Database (CTRD) Group.

K L Grady1, C White-Williams, D Naftel, M R Costanzo, D Pitts, B Rayburn, A VanBakel, B Jaski, R Bourge, J Kirklin.   

Abstract

BACKGROUND: The relationship between pre-transplant body weight and post-transplant outcome has only recently been identified using a single, indirect measure of weight (percent ideal body weight [PIBW]). The literature is equivocal regarding which index is the better indicator of body weight. The purpose of this study was to determine (1) if pre-heart transplant body weight, measured by body mass index (BMI) and PIBW, is associated with post-heart transplant morbidity and mortality and (2) if patient gender, age, and etiology of heart disease affect this association.
METHODS: The sample included 4,515 patients who received a heart transplant from January 1, 1990-December 31, 1995 at 38 institutions participating in the Cardiac Transplant Research Database (CTRD). Patients were divided into groups according to their BMI and PIBW. Data were described using frequencies, measures of central tendency, Pearson correlation coefficients, stratified actuarial analyses and log rank tests for comparisons, and a multivariable risk factor analysis in the hazard domain.
RESULTS: For all patients (n = 4,515), being <80% or >140% of IBW before heart transplant was a risk factor for increased mortality after heart transplant. The association between pre-heart transplant PIBW and post-heart transplant survival was affected by gender, age, and etiology of heart disease. In males, a higher PIBW was a significant risk factor for death early after transplant (p = .0003). Although not significant, there was a trend for a higher PIBW being a risk factor for death in females throughout the post transplant period (p = .07). No differences in cause of death were found for PIBW and BMI. In male and female recipients <55 years, being overweight pre-heart transplant was a risk factor for infection. In patients with pre-transplant ischemic heart disease, the greatest risk for infection was found in patients who were >140% of IBW. Pre-heart transplant BMI and PIBW were not associated with acute rejection or cardiac allograft arteriopathy after transplant.
CONCLUSIONS: In conclusion, being cachectic or obese preoperatively is associated with decreased survival in all patients after heart transplantation. Being obese preoperatively is associated with increased infection after heart transplant in males and females <55 years and in patients with ischemic heart disease. Of the 2 indices of body weight used in this study, percent ideal body weight appears to be the better predictor of future morbidity and mortality following heart transplantation.

Entities:  

Mesh:

Year:  1999        PMID: 10512521     DOI: 10.1016/s1053-2498(99)00035-2

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  15 in total

1.  Impact of Obesity on Ventricular Assist Device Outcomes.

Authors:  Abhishek Jaiswal; Lauren K Truby; Astha Chichra; Rashmi Jain; Leann Myers; Nirav Patel; Veli K Topkara
Journal:  J Card Fail       Date:  2019-10-13       Impact factor: 5.712

2.  No Obesity Paradox in Pediatric Patients With Dilated Cardiomyopathy.

Authors:  Chesney D Castleberry; John L Jefferies; Ling Shi; James D Wilkinson; Jeffrey A Towbin; Ryan W Harrison; Joseph W Rossano; Elfriede Pahl; Teresa M Lee; Linda J Addonizio; Melanie D Everitt; Justin Godown; Joseph Mahgerefteh; Paolo Rusconi; Charles E Canter; Steven D Colan; Paul F Kantor; Hiedy Razoky; Steven E Lipshultz; Tracie L Miller
Journal:  JACC Heart Fail       Date:  2018-02-07       Impact factor: 12.035

3.  Clinical outcomes in overweight heart transplant recipients.

Authors:  Anne Jalowiec; Kathleen L Grady; Connie White-Williams
Journal:  Heart Lung       Date:  2016-04-14       Impact factor: 2.210

4.  The varying effects of obesity and morbid obesity on outcomes following cardiac transplantation.

Authors:  J Nagendran; M D Moore; C M Norris; A Khani-Hanjani; M M Graham; D H Freed; J Nagendran
Journal:  Int J Obes (Lond)       Date:  2016-02-08       Impact factor: 5.095

Review 5.  Implications of obesity in cardiac surgery: pattern of referral, physiopathology, complications, prognosis.

Authors:  Luca Salvatore De Santo; Caesar Moscariello; Carlo Zebele
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

6.  Obesity is associated with increased morbidity but not mortality in critically ill patients.

Authors:  Yasser Sakr; Christian Madl; Daniela Filipescu; Rui Moreno; Johan Groeneveld; Antonio Artigas; Konrad Reinhart; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2008-08-01       Impact factor: 17.440

7.  Patterns and predictors of physical functional disability at 5 to 10 years after heart transplantation.

Authors:  Kathleen L Grady; David C Naftel; James B Young; Dave Pelegrin; Jennifer Czerr; Robert Higgins; Alain Heroux; Bruce Rybarczyk; Mary McLeod; Jon Kobashigawa; Julie Chait; Connie White-Williams; Susan Myers; James K Kirklin
Journal:  J Heart Lung Transplant       Date:  2007-09-27       Impact factor: 10.247

8.  High-Fat Diet-Induced Obesity Enhances Allograft Rejection.

Authors:  Luciana L Molinero; Dengping Yin; Yuk Man Lei; Luqiu Chen; Ying Wang; Anita S Chong; Maria-Luisa Alegre
Journal:  Transplantation       Date:  2016-05       Impact factor: 4.939

9.  The impact of extreme obesity on outcomes after left ventricular assist device implantation.

Authors:  Gardner Yost; Laura Coyle; Colleen Gallagher; Nicole Graney; Roxanne Siemeck; Antone Tatooles; Patroklos Pappas; Geetha Bhat
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

10.  Combined Ventricular Assist Device Placement With Adjustable Gastric Band (VAD-BAND): A Promising New Technique for Morbidly Obese Patients Awaiting Potential Cardiac Transplantation.

Authors:  Richdeep S Gill; Shahzeer Karmali; Jeevan Nagandran; Howard O Frazier; Vadim Sherman
Journal:  J Clin Med Res       Date:  2012-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.